Stay updated on Tizanidine in Cerebral Palsy Pediatric Clinical Trial
Sign up to get notified when there's something new on the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page.

Latest updates to the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial record for the Phase 1b study of tizanidine in children with cerebral palsy is now displayed, including its terminated status and detailed study information.SummaryDifference40%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label was updated from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice about NIH website updates and the transition to using “Super Intelligence” in place of “Artificial Intelligence” appears above the 403 error.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe revision number in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study record. This blocks access to the core study details and site navigation.SummaryDifference0.5%

Stay in the know with updates to Tizanidine in Cerebral Palsy Pediatric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tizanidine in Cerebral Palsy Pediatric Clinical Trial page.